Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (HKG:2315)
Hong Kong
· Delayed Price · Currency is HKD 22.65
+0.50 (2.26%)
Jun 27, 2025, 3:59 PM HKT
HKG:2315 Market Cap
HKG:2315 has a market cap or net worth of 9.05 billion as of June 27, 2025. Its market cap has increased by 152.51% in one year.
Market Cap
9.05B
Enterprise Value
9.22B
Revenue
1.04B
Ranking
n/a
PE Ratio
252.56
Stock Price
22.65
Market Cap Chart
Since September 1, 2022, HKG:2315's market cap has decreased from 10.31B to 9.05B, a decrease of -12.29%. That is a compound annual growth rate of -4.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 27, 2025 | 9.05B | 166.47% |
| Dec 31, 2024 | 3.39B | -29.05% |
| Dec 29, 2023 | 4.78B | -53.29% |
| Dec 30, 2022 | 10.24B | -0.67% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines | 237.03B |
| Hansoh Pharmaceutical Group Company | 173.02B |
| JD Health International | 135.68B |
| Innovent Biologics | 129.81B |
| WuXi Biologics | 101.72B |
| Sino Biopharmaceutical | 92.46B |
| CSPC Pharmaceutical Group | 89.38B |
| Akeso | 85.14B |